Replies to post #43042 on Avid Bioservices Inc (CDMO)

[jakedogman1]

Agree on the BOD. And they don't want someone with experience (and character) looking over their shoulders. ES and crew provide zero value. I take that back. Less than zero value.

Their collective experience is penny stock offshore pipes and securities law. The only guidance they provide SK is how to screw shareholders and get away with it.

[geocappy1]

My best spin is it depends on how much the authorized shares eventually are sold for. If they were able to sell each of the remaining 275M shares for $6 each then the company would have $1.6B in the bank and all shareholders would be in better shape depending on how the company spent the money. if the company sells the shares for less than $3.20 per share and spend the money on things that do not boost the value then we get diluted.

Time will tell.

[Charlie Stein]

I'm with you all the way. Swartz took over the company by investing $20 million. He then instituted a poison pill and sold almost all his stock, but between the poison pill and shareholder apathy, he and his cronies can stay in power forever, rewarding themselves with high directors' fees and stock options.

Now watch them give themselves a high percentage of the company and then sell it.

[bfiest]

Unfortunately this appears to be right on. So much potential but greed may be paving the way. I hope you are wrong but this seems to be an insightful post based on the actual history of this company. You just can't close your eyes to it anymore. I just wish we as shareholders could be more objective and really base our collective opinions on the dealings of the past. Everything right with the science yet here we are exercising a 5-1 reverse split at 60 cents. It's time to open our collective eyes. I hope for a lot of investors sake that this analysis is wrong. I will be the first to happily admit it if it is. Have to hang on to some hope. I will vote based on the actual historical track record of this management group. Open your eyes and see clearly.

[jakedogman1]

Agree 100%. SK and crew have stated that the reason they can't get institutional investment is because of the capital structure. Another key investment criteria is mgmt structure. The current board has zero biotech experience and has experience with shady pipes and penny stocks. And even worse is that they are all tied together through ES. SK has zero deal making experience unless you count the DIOS deal (very shady) and Affitech which is like kissing your sister. How will SK correct this problem when you stated quite well that he is ES's Biotch?

The sad part is that mgmt and the BOD own very little shares. I would bet there are 20 posters on this board that own three times or more the shares mgmt own. If things don't change soon, shareholders need to get together and make sure mgmt listens. And independent director with biotech experience would be a first step. My guess is ES would fight it. Sorry but we need accountability.